Belatacept in Kidney Transplantation of Moderately Sensitized Patients
Conditions: End Stage Renal Disease; Antibody Mediated Rejection
Interventions: Drug: Belatacept; Drug: Tacrolimus withdrawal; Procedure: Plasmapheresis/Intravenous Immunoglobulin G; Drug: Thymoglobulin (ATG); Drug: Myfortic; Drug: Steroids
Sponsors: University of Wisconsin, Madison; Bristol-Myers Squibb
Recruiting - verified May 2016
Interventions: Drug: Belatacept; Drug: Tacrolimus withdrawal; Procedure: Plasmapheresis/Intravenous Immunoglobulin G; Drug: Thymoglobulin (ATG); Drug: Myfortic; Drug: Steroids
Sponsors: University of Wisconsin, Madison; Bristol-Myers Squibb
Recruiting - verified May 2016